Human Resources

ACETO Appoints Edward J. Borkowski Chief Financial Officer

February 19, 2018

PORT WASHINGTON, N.Y., Feb. 16, 2018 (GLOBE NEWSWIRE) — ACETO Corporation (Nasdaq:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced that it has appointed Edward J. Borkowski as Chief Financial Officer effective February 21, 2018. “Ed brings the right combination of pharmaceutical […]

Saneca Pharma appoints new CEO

February 19, 2018

Contract development and manufacturing organisation (CDMO) Saneca Pharma has announced the appointment of its new CEO, Richard Král. Richard, who has been the sales and marketing director at Saneca for almost three years, has previously worked for GlaxoSmithKline and Zentiva Group across the Central and Eastern Europe (CEE) and the Commonweath of Independent States (CIS) […]

Matthew Gagalis Joins Pri-Med Educational Development Team

February 14, 2018

BOSTON, Feb. 13, 2018 /PRNewswire/ — Matt Gagalis, a healthcare executive, was named General Manager, Continuing Medical Education Programs of DBC Pri-Med, LLC, a division of Diversified Communications, located in Boston, MA, that provides the latest medical education to primary care clinicians. Previously, Matt held leadership positions at RxAnte, an advanced healthcare analytics and clinical […]

Sobi Names Linea Aspesi Vice President of Human Resources in North America

February 14, 2018

WALTHAM, Mass.–(BUSINESS WIRE)–Sobi, a pioneering international biopharmaceutical company dedicated to rare and difficult-to-treat diseases, announced today the appointment of Linea Aspesi as vice president of human resources for North America.   “Sobi is committed to growing our footprint in North America, and Linea’s experience both recruiting and developing teams will be critical to support this […]

Aptinyx Appoints Ashish Khanna Chief Financial Officer and Chief Business Officer

February 14, 2018

Evanston, Ill., Feb. 13, 2018 – Aptinyx Inc., a clinical-stage biopharmaceutical company developing transformative therapies for challenging neurologic disorders, today announced Ashish Khanna, the company’s chief business officer, has also been appointed its chief financial officer. Mr. Khanna’s role includes oversight of all finance and accounting in addition to corporate and business development. He led […]

Ashfield U.S. hires two senior executives for new Medical Affairs business unit

February 14, 2018

Feb 13 2018-Fort Washington, PA: Ashfield U.S., part of UDG Healthcare plc, a global leader in commercialization services for the pharmaceutical and healthcare industry, is pleased to announce the appointment of Amy Van Sant as President of their new Medical Affairs business unit and Lee Ann Chaiken as Senior Vice President of Ashfield’s Pharmacovigilance business.   […]

Bracket Appoints New CEO Michael Nolte

February 14, 2018

February 12, 2018, Wayne, PA – Bracket, a leading clinical trial technology and specialty services provider, today announced the appointment of Michael P. Nolte as Chief Executive Officer. The company’s current CEO, Jeff Kinell, will remain on the Bracket Board of Directors as a strategic advisor. Mike Nolte is a seasoned industry leader who joins […]

Envigo appoints Lynn Lewis as Senior Vice President of Global Sales

February 14, 2018

EAST MILLSTONE, N.J., Feb. 13, 2018 (GLOBE NEWSWIRE) — Envigo, a leading provider of nonclinical contract research services and research models, today announced the appointment of Lynn Lewis to the position of Senior Vice President, Global Sales. She brings extensive knowledge in both science and business to the company through her successful career in pharmaceuticals […]

ImmunoMet Appoints Vincent J. O’Neill, M.D., B.Sc., M.R.C.P, as Chief Medical Officer, and Allan L. Shaw as Chief Financial Officer

February 13, 2018

HOUSTON, Feb. 12, 2018 /PRNewswire/ — ImmunoMet Therapeutics, a private biotechnology company focused on utilizing cellular metabolism to develop novel anti-tumor and immuno-oncology therapies, today announced the appointment of Vincent J. O’Neill, M.D., B.Sc., M.R.C.P., as Chief Medical Officer and Allan J. Shaw as Chief Financial Officer.   Benjamin Cowen, Chief Executive Officer of ImmunoMet, […]

CRF Health Extends Product Strategy and Innovation Team with Industry Pioneer

February 13, 2018

Plymouth Meeting, PA – February 12, 2018: CRF Health, a leading global provider of patient-centered eSource technology and service solutions for the life sciences industry, has today announced the appointment of Bill Byrom as Vice President of Product Strategy & Innovation. Byrom, who brings more than two decades of pioneering industry experience to CRF Health, […]

Sangamo Therapeutics Announces Appointment Of Heather D. Turner As Senior Vice President And General Counsel

February 13, 2018

RICHMOND, Calif., Feb. 12, 2018 /PRNewswire/ — Sangamo Therapeutics, Inc. (Nasdaq: SGMO) today announced the appointment of Heather D. Turner as senior vice president and general counsel, effective immediately. Ms. Turner will oversee all legal matters for the Company and will report to Sangamo’s chief executive officer.   “I’m delighted to have Heather join Sangamo […]

Bracket Appoints Michael Nolte as New CEO

February 13, 2018

WAYNE, Pa., Feb. 13, 2018 /PRNewswire/ — Bracket, a leading clinical trial technology and specialty services provider, today announced the appointment of Michael P. Nolte as Chief Executive Officer. The company’s current CEO, Jeff Kinell, will remain on the Bracket Board of Directors as a strategic advisor.   Mike Nolte is a seasoned industry leader […]

Charles River Laboratories Announces Executive Management Appointments

February 13, 2018

WILMINGTON, Mass.–(BUSINESS WIRE)–Charles River Laboratories International, Inc. (NYSE: CRL) today announced two new executive management appointments.   Dr. Davide Molho, Corporate Executive Vice President and President, Global Research Models & Services, Safety Assessment and Biologics, will become President and Chief Operating Officer of Charles River, effective immediately, and will add Discovery Services to his responsibilities. […]

Ardelyx Announces Departure of Chief Scientific Officer

February 12, 2018

FREMONT, Calif., Feb. 12, 2018 /PRNewswire/ — Ardelyx, Inc. (NASDAQ: ARDX) today announced that Jeremy Caldwell, Ph.D., chief scientific officer, will be leaving the company, effective February 16, 2018, to pursue a position as chief executive officer of an early stage biotech start-up company based in San Diego.   “Jeremy has been a tremendous asset […]

Regeneron Announces Appointment of Marion McCourt as Senior Vice President and Head of Commercial

February 12, 2018

TARRYTOWN, N.Y., Feb. 12, 2018 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), today announced the appointment of Marion McCourt as the Senior Vice President and Head of Commercial. Ms. McCourt joined Regeneron today to lead all aspects of product commercialization for Regeneron’s currently approved medicines and development-stage pipeline.   “Marion is an accomplished biopharmaceutical executive […]

Aerie Pharmaceuticals Announces Appointment of Scott Cassady as Regional Sales Director for the Central Region

February 12, 2018

DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma and other diseases of the eye, today announced the appointment of Scott Cassady as Regional Sales Director for the Central Region, reporting to Gary Menichini, Aerie’s Vice […]

Surface Oncology Promotes Jeff Goater to Chief Executive Officer

February 12, 2018

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Surface Oncology, an immuno-oncology company developing next-generation antibody therapies that target the tumor microenvironment, announced today that Jeff Goater, currently the company’s chief business officer, has been promoted to chief executive officer. Mr. Goater succeeds interim chief executive officer Dan Lynch, who will remain executive chairman of Surface’s board of directors. Mr. Goater, […]

Symcel expands staff for clinical market growth and Horizon 2020 funded validation of antimicrobial susceptibility testing

February 12, 2018

7 February 2018: Symcel – the company behind the revolutionary cell-based assay tool for real-time cell metabolism measurements, calScreener™ – is expanding to bring its patented technology to the clinical antimicrobial susceptibility testing (AST) markets. The company states it is a key time in its strategic development and, with an increased global focus, Symcel forecasts […]

Acceleron Announces Appointment of Chief Commercial Officer

February 9, 2018

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Acceleron Pharma Inc. (NASDAQ:XLRN), a leading biopharmaceutical company in the discovery and development of TGF-beta therapeutics to treat serious and rare diseases, today announced the appointment of commercial industry leader, Sujay Kango as Chief Commercial Officer (CCO). He brings over 25 years of commercial leadership and expertise, in both biotechnology and large pharmaceutical […]

BioStem Technologies Adds Chief Revenue Officer to Executive Team

February 9, 2018

Pompano Beach, FL, Feb. 08, 2018 (GLOBE NEWSWIRE) — (GLOBE NEWSWIRE) – BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), a global life sciences corporation, providing innovative technologies with a concentration in Pharmaceuticals and Regenerative Medicine, announced today, the hiring of Larry Jones, as Chief Revenue Officer. Mr. Jones comes to BioStem Tech […]

Syneos Health Names Lisa van Capelle Chief Human Resources Officer

February 8, 2018

RALEIGH, N.C., Feb. 08, 2018 (GLOBE NEWSWIRE) — Syneos Health™ (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, has announced the appointment of Lisa van Capelle as Chief Human Resources Officer (CHRO). van Capelle will guide a workforce of approximately 21,000 employees to deliver high-value, integrated clinical and commercial solutions to customers worldwide. Prior to […]

Evelo Biosciences Expands Executive Leadership Team

February 8, 2018

CAMBRIDGE, Mass., Feb. 8, 2018 /PRNewswire/ — Evelo Biosciences, a biotechnology company pioneering the therapeutic modality of monoclonal microbials, today announced the expansion of its executive leadership team with the appointment of Duncan McHale, M.D., Ph.D. as chief medical officer and Michael Garcia-Webb, Ph.D. as head of people and operational excellence.   “I am pleased […]

David Kendall Joins MannKind as Chief Medical Officer

February 8, 2018

WESTLAKE VILLAGE, Calif., Feb. 06, 2018 (GLOBE NEWSWIRE) — MannKind Corporation (NASDAQ:MNKD) today announced that David M. Kendall, MD, will join the company as Chief Medical Officer and assume full responsibility for leading MannKind’s scientific research, clinical development, regulatory, and medical affairs activity, effective February 12. Dr. Kendall will report directly to Michael Castagna, Pharm.D., […]

Pernix Announces Appointment of Lead Independent Director and Key Management Team Promotion

February 7, 2018

MORRISTOWN, N.J., Feb. 06, 2018 (GLOBE NEWSWIRE) — Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, today announced the appointment of Director John R. Leone as its Lead Independent Director. Mr. Leone joined the Pernix Board of Directors in November 2017. He is currently an Operating Partner at Madryn Asset Management, an investment fund […]

Arcturus Therapeutics Issues Statement

February 7, 2018

SAN DIEGO, Feb. 06, 2018 (GLOBE NEWSWIRE) — Arcturus Therapeutics Ltd. (NASDAQ:ARCT), a leading RNA medicines company, today issued the following statement in response to the 13D filing issued by Joseph E. Payne: We are aware of the 13D filing by Joseph E. Payne, Arcturus’ former President and Chief Executive Officer, who was terminated on […]

Symcel expands staff for clinical market growth and Horizon 2020 funded validation of antimicrobial susceptibility testing

February 7, 2018

calScreener™ to become the industry gold standard for combination testing of antibiotics within five years 7 February 2018: Symcel – the company behind the revolutionary cell-based assay tool for real-time cell metabolism measurements, calScreener™ – is expanding to bring its patented technology to the clinical antimicrobial susceptibility testing (AST) markets. The company states it is […]

Liquidia Technologies Appoints Kevin Gordon as President and Chief Financial Officer

February 6, 2018

RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–Liquidia Technologies, Inc., a late-stage clinical biopharmaceutical company focused on improving the performance of medicine by precisely engineering drug particles, today announced the appointment of Kevin Gordon as President and Chief Financial Officer. Mr. Gordon will oversee finance operations and strategy, corporate development and legal functions.   “We look forward to […]

Gisela Abbam Is Abt Associates’ New Director of Strategic Partnerships

February 6, 2018

BETHESDA, Maryland, Feb. 6, 2018 /PRNewswire/ — Operating out of Abt Associates’ London office, Gisela Abbam is the company’s new Director of Strategic Partnerships. Abbam has worked with WHO, World Bank, UN, NGOs and governments around the world, and she’ll leverage that experience as she helps identify and recruit partners who can help Abt advance […]

Sinclair Research Appoints G. Alex Wakefield as Vice President of Research and Operations

February 6, 2018

Columbia, Mo., Feb. 6, 2018 (Business Wire) — Sinclair Research, one of the nation’s leading providers of preclinical services, is pleased to announce new executive leadership with the arrival of G. Alex Wakefield, DVM, as vice president of research and operations. In this newly created role, Wakefield will have overall responsibility for the company’s research […]

Arcturus Therapeutics Appoints Mark Herbert as Interim President

February 5, 2018

SAN DIEGO, Feb. 02, 2018 (GLOBE NEWSWIRE) — Arcturus Therapeutics Ltd. (NASDAQ:ARCT), a leading RNA medicines company, today announced that Mark R. Herbert, Vice President of Business Development and Alliance Management, has been appointed to serve as Interim President, effective immediately. This appointment follows the decision of the Arcturus Board of Directors to terminate Joseph […]

FEEDBACK